We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGO
3326
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$28K ﹤0.01%
1,180
+747
+173% +$17.3K
SRRA
3327
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$28K ﹤0.01%
+1,305
New +$28.8K
RBNC
3328
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$28K ﹤0.01%
771
-576
-43% -$19.6K
FBC
3329
DELISTED
Flagstar Bancorp, Inc. New
FBC
$28K ﹤0.01%
575
-18,958
-97% -$940K
ABTS icon
3330
Abits Group
ABTS
$4.24M
$27K ﹤0.01%
+627
New +$50.6K
ATNI icon
3331
ATN International
ATNI
$488M
$27K ﹤0.01%
671
+482
+255% +$20.6K
BATRA icon
3332
Atlanta Braves Holdings Series A
BATRA
$3.68B
$27K ﹤0.01%
955
+217
+29% +$6.27K
BDSX icon
3333
Biodesix
BDSX
$253M
$27K ﹤0.01%
256
+173
+208% +$22.6K
BSRR icon
3334
Sierra Bancorp
BSRR
$532M
$27K ﹤0.01%
991
-372
-27% -$9.62K
BSVN icon
3335
Bank7 Corp
BSVN
$498M
$27K ﹤0.01%
1,151
+1,015
+746% +$24.4K
CMCT
3336
Creative Media & Community Trust
CMCT
$14M
0
CUE icon
3337
Cue Biopharma
CUE
$233M
$27K ﹤0.01%
79
-14
-15% -$5.41K
DSGN icon
3338
Design Therapeutics
DSGN
$928M
$27K ﹤0.01%
1,271
+825
+185% +$14.2K
EEFT icon
3339
Euronet Worldwide
EEFT
$2.74B
$27K ﹤0.01%
227
-199
-47% -$23.7K
ERAS icon
3340
Erasca
ERAS
$6.43B
$27K ﹤0.01%
1,735
+754
+77% +$12.9K
EVRI
3341
DELISTED
Everi Holdings
EVRI
$27K ﹤0.01%
1,272
-7,980
-86% -$182K
EWC icon
3342
iShares MSCI Canada ETF
EWC
$6.56B
$27K ﹤0.01%
693
-330
-32% -$12.7K
ZSTK
3343
ZeroStack Corp
ZSTK
$33.9M
$27K ﹤0.01%
19
+18
+1,800% +$49.4K
FRO icon
3344
Frontline
FRO
$9.17B
$27K ﹤0.01%
3,831
-93
-2% -$742
JANX icon
3345
Janux Therapeutics
JANX
$986M
$27K ﹤0.01%
1,384
+862
+165% +$18.1K
JRVR icon
3346
James River Group Holdings
JRVR
$193M
$27K ﹤0.01%
953
-3,297
-78% -$102K
PACK icon
3347
Ranpak Holdings
PACK
$478M
$27K ﹤0.01%
721
-3,165
-81% -$112K
PBA icon
3348
Pembina Pipeline
PBA
$28.7B
$27K ﹤0.01%
900
+30
+3% +$956
QTWO icon
3349
Q2 Holdings
QTWO
$4.04B
$27K ﹤0.01%
340
-10,908
-97% -$880K
ROAD icon
3350
Construction Partners
ROAD
$6.9B
$27K ﹤0.01%
933
-535
-36% -$18.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.